genOway Société anonyme (EPA:ALGEN)
France
· Delayed Price · Currency is EUR 2.460
-0.040 (-1.60%)
Apr 28, 2026, 3:57 PM CET
genOway Société anonyme Revenue
In the year 2025, genOway Société anonyme had annual revenue of 20.96M EUR, down -23.88%. genOway Société anonyme had revenue of 8.09M in the half year ending December 31, 2025, a decrease of -45.51%.
Revenue
20.96M
Revenue Growth
-23.88%
P/S Ratio
1.08
Revenue / Employee
141.59K
Employees
148
Market Cap
22.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.96M | -6.58M | -23.88% |
| Dec 31, 2024 | 27.53M | 1.02M | 3.85% |
| Dec 31, 2023 | 26.51M | 5.26M | 24.76% |
| Dec 31, 2022 | 21.25M | 1.46M | 7.38% |
| Dec 31, 2021 | 19.79M | 3.47M | 21.30% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GenSight Biologics | 652.00K |
| Advicenne | 5.90M |
| Aelis Farma | 2.33M |
| Aton | 656.93K |
| Nicox | 3.32M |
| Poxel | 7.66M |
| NFL Biosciences | 188.00 |
| THX Pharma Société Anonyme | 876.13K |